Search

563 results:
Search results 241 until 250 of 563
241. [BIPS Project] Primary prevention early in life: effects of the pro kind intervention in adolescence   The Pro Kind home visiting program for first-time socially disadvantaged mothers. Midwifes and social workers offer support to the mothers from pregnancy to the child's second birthday. The primary…  
242. [BIPS Project] Preventive services and socio-economic status in Germany   In Germany, vaccination against Human papilloma viruses (HPV) is recommended by the Standing Committee on Vaccination (STIKO) for all girls and boys aged 9 to 14. They should preferably be concluded…  
243. [BIPS Project] PRESENT - Primary prevention and health promotion reseach networks coodination   The objectives of the project are the joint coordination and publicity of the five BMBF-funded research networks on primary prevention and health promotion (HLCA, CAPITAL4HEALTH, PartKommPlus,…  
245. [BIPS Project] Prescription behavior of HIV therapeutics in women of childbearing age and during pregnancy in Germany   At the end of 2019, there were approximately 80,000 persons with a diagnosed infection with the human immunodeficiency virus (HIV) in Germany, including about 9,000 girls and women of childbearing…  
246. [BIPS Project] Prenatal and childhood immunization and the risk of childhood cancer   Risk factors for most childhood cancers are unknown. Currently, there are some protective factors acting via immunological pathways, like infections and particularly vaccinations, under discussion.…  
247. [BIPS Project] Post-marketing drug utilization study for galcanezumab   Galcanezumab is a humanised monoclonal antibody against human calcitonin gene-related peptide and is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month…  
248. [BIPS Project] Post-authorization safety study on agomelatine and the risk of hospitalization for acute liver injury   Agomelatine (Valdoxan, Thymanax) is a melatonergic agonist and 5-HT2C antagonist which is, among other antidepressants, indicated for major depressive episodes in adults. Its marketing authorisation…  
249. [BIPS Project] Post-authorisation safety study of tralokinumab use in pregnancy   Tralokinumab is a biological agent developed for the treatment of moderate to severe atopic dermatitis (AD) and is administered by subcutaneous injection. Tralokinumab is a fully human immunoglobulin…  
250. [BIPS Project] Post-authorisation safety study of nocdurna for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria: A multi-country cohort study using secondary data   Nocdurna (desmopressin) has been approved in Germany since January 2017 for the treatment of nocturia in adult patients with idiopathic nocturnal polyuria. Desmopressin is an analog of the…  
Search results 241 until 250 of 563